Cancer in children and adolescents is rare but remains one of the leading causes of death in this age group. Survivors often face long-term health issues, including higher risks of illness and mortality. Understanding the genetic causes of childhood cancer is critical for developing better treatments, early detection, and even prevention.
The Role of Genetics in Childhood Cancer
The most significant risk factor for cancer in children and adolescents is genetic predisposition. Certain cancer predisposition genes (CPGs) contain variants that increase the risk of developing cancer. These hereditary conditions are often referred to as cancer predisposition syndromes (CPS), such as:
- Li-Fraumeni syndrome
- Fanconi anemia
Around 10% of children and adolescents with cancer have CPS. These genetic mutations can be inherited or occur spontaneously during embryonic development, leading to a mix of altered and healthy cells—a condition known as mosaic disease.
Environmental and Genetic Interactions
While hereditary gene variants play a major role, environmental factors like viral infections can also contribute to childhood cancers. The interaction between multiple genetic factors and environmental triggers creates a complex picture of cancer risk.
Progress Over 40 Years
The first cancer predisposition gene was identified 40 years ago, marking a turning point in our understanding of genetic risks. Since then, significant advancements have been made:
- Identifying Gene Variants: Scientists have discovered many more CPGs associated with childhood cancers.
- Understanding Hereditary Patterns: Research has shown that both common gene variants and rare mutations at multiple gene loci can contribute to cancer risk.
- Improved Screening and Treatment: Advances in genetic testing now allow for earlier detection and more personalized treatments for affected children.
Insights from Current Research
Professor Christian Kratz, Director of the Department of Paediatric Haematology and Oncology at MHH, highlights the importance of understanding the genetic and environmental causes of cancer in children. His recent review paper, published in Nature Reviews Cancer, summarizes decades of research and sheds light on the complexity of cancer predisposition syndromes.
The review emphasizes that genetic research is essential for:
- Developing better treatments for childhood cancers.
- Early detection through genetic screening programs.
- Potential prevention in high-risk individuals.
Key Takeaways for Doctors
- Focus on Genetics: Understanding cancer predisposition genes (CPGs) can help identify children at higher risk.
- Comprehensive Care: Be aware of cancer predisposition syndromes (CPS) like Li-Fraumeni syndrome and Fanconi anemia in pediatric oncology cases.
- Personalized Medicine: Utilize genetic testing to guide treatment and long-term care for survivors.
- Environmental Awareness: Recognize the role of environmental factors in cancer risk and incorporate preventive strategies where possible.
Conclusion
Four decades of research have revolutionized our understanding of the genetic causes of childhood and adolescent cancers. By focusing on genetic predisposition, healthcare professionals can offer better care, earlier detection, and potentially life-saving prevention strategies for young patients.
The ongoing work in this field promises to further improve outcomes and reduce the burden of cancer in this vulnerable population.
To register for our next masterclass please click here https://linktr.ee/docpreneur
